You searched for metabolic diseases - Page 56 of 63

News and Trends 29 May 2020

AI Drug Discovery Firm Exscientia Closes €54M Series C

…for an undisclosed rare metabolic disease. “The opportunities the platform gives us are broad, hence such joint ventures enable us to scale the pipeline by combining our drug discovery platform…

May 29, 2020 - 3 minutesmins - By David Kirk

News and Trends 22 Jun 2023

FDA approves type 2 diabetes drug for children 10 and older

…improve outcomes for this population and supports our larger commitment to advance treatment options for people living with a range of cardiometabolic conditions.” Jardiance is not recommended in patients with…

June 22, 2023 - 3 minutesmins - By Jim Cornall

Orchard therapeutics gene therapy header

News and Trends 1 Nov 2018

Gene Therapy Company’s IPO Shoots it to Billion-Euro Biotech List

Orchard Therapeutics, a British company developing gene therapy for rare genetic diseases, has launched its Nasdaq IPO and is now reportedly worth $1.25B (€1B). This IPO propels Orchard to the…

November 1, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 15 Sep 2021

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

…The technology could potentially tackle a plethora of seemingly unrelated diseases, including infections, metabolic disorders, and cancer. The Scottish investment firm Thairm Bio led the financing, with US-based Kineticos Ventures…

September 15, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 17 Oct 2017

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

…therapeutics for metabolic and inflammatory diseases. Its lead candidate, elafibranor, targets Non-Alcoholic Stato-Hepatitis (NASH) – an inflammatory disease of the liver. The company has raised €180M by selling bonds that…

October 17, 2017 - 3 minutesmins - By Alex Dale

News and Trends 1 Oct 2018

Cancer-Sniffing Diagnostics Company Secures €43.1M Funding

…other diseases such as tuberculosis, asthma, and inflammatory bowel disease. For example, GSK showed interest in the device last year, using it in a clinical trial of its treatment for…

October 1, 2018 - 2 minutesmins - By Jonathan Smith

More News! 21 Dec 2022

Watch: Aphaia Pharma interview

…metabolic disorders such as obesity and associated diseases. Aphaia Pharma’s lead candidate, APH-012, a glucose formulation, has been shown to safely restore endogenous hormone release in individuals with obesity. APH-012…

December 21, 2022 - 1 minutemin - By Jim Cornall

evolva us navy composite material synbio

News and Trends 14 Apr 2016

European Biotech teams up with US Navy to engineer Military Materials

…light, and BacHBerry, to bio-mine the metabolic diversity of berries – an increasingly popular strategy. Biotechnology is increasingly being used to develop smarter materials, from biodegradable bioplastics from potatoes to…

April 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 3 Apr 2020

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

…cell growth through targeting metabolic pathways has the potential to deliver new approaches to treat a wide range of severe diseases.” The UK company has only shared minimal information about…

April 3, 2020 - 2 minutesmins - By Helen Albert

News and Trends 7 Oct 2016

Meet the ‘Haut-Couturiers’ of Bioengineering

…and deletion of genes and the modification of metabolic pathways in bacterial strains and yeasts, enabling the development of efficient bioproduction systems. The great innovation of this site-specific technology is…

October 7, 2016 - 3 minutesmins - By Jerome Topsent

News and Trends 6 Dec 2022

Avalon BioVentures to invest in early-stage biotech

…50 biotech and health tech companies. Portfolio companies have advanced drug candidates across a broad range of disease indications including cancer, celiac disease, infectious disease, metabolic disease, neurodegeneration, and rare…

December 6, 2022 - 2 minutesmins - By Jim Cornall

tumor cancer immunotherapy alderaan biotech

News and Trends 17 Jun 2020

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

…in cancer as well as other diseases such as malaria and metabolic conditions. One of the most advanced oncology biotechs targeting this same protein is US-based Vigeo Therapeutics, whose lead…

June 17, 2020 - 2 minutesmins - By Victor Kotsev

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

AI Drug Discovery Firm Exscientia Closes €54M Series C

FDA approves type 2 diabetes drug for children 10 and older

Gene Therapy Company’s IPO Shoots it to Billion-Euro Biotech List

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

Cancer-Sniffing Diagnostics Company Secures €43.1M Funding

Watch: Aphaia Pharma interview

European Biotech teams up with US Navy to engineer Military Materials

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

Meet the ‘Haut-Couturiers’ of Bioengineering

Avalon BioVentures to invest in early-stage biotech

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!